Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 9

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 9
---
 in mind that there may be actual or potential material conflicts of interest between or among (i) the Sponsor, its affiliates, certain HVII directors and officers, or promoters and (ii) unaffiliated security holders of HVII. Such conflicts of interest may include a material conflict of interest arising in determining whether to proceed with the Business Combination and a material conflict of interest arising from the interest that the Sponsor and its affiliates have in the Business Combination. Also, ONE Nuclear and its officers have financials interests that are different from, or in addition to, the interests of unaffiliated HVII shareholders, which could cause ONE Nuclear to pursue terms in the Business Combination that are less favorable to non-redeeming shareholders. For additional information, see “ The Business Combination— Interests of Certain Persons in the Business Combination” and “ Summary of the Proxy Statement/Prospectus — Interests of HVII’s Officers and Directors in the Business Combination.” The HVII Board was aware of and considered these interests, among other matters, in evaluating the Business Combination, and in recommending to HVII’s shareholders that they approve the Business Combination.

Upon the Closing, the Sponsor and HVII’s directors and officers will receive an aggregate of (i) 6,333,333 shares of New ONE Nuclear Common Stock in respect of the outstanding 6,333,333 HVII Class B Ordinary Shares, which were purchased for an aggregate purchase price of $25,000, and (ii) 747,500 shares of New ONE Nuclear Common Stock in respect of the Sponsor’s outstanding 500,000 HVII units, which were purchased for an aggregate purchase price of $5 million simultaneously with the consummation of the IPO. In addition, HVII pays $25,000 per month to an affiliate of the Sponsor for office space, utilities and secretarial and administrative support. If the Sponsor, an affiliate of the Sponsor, or HVII’s officers and directors make any working capital loans to HVII, up to $2,500,000 of such working capital loans may be convertible into private placement units of HVII at a price of $10.00 per unit at the option of the lender. The compensation received or to be received by the Sponsor, its affiliates, and HVII’s officers and directors and the securities to be issued to the Sponsor, its affiliates, and HVII’s officers and directors in connection with the Closing, may result in a material dilution of the equity interest of non-redeeming public shareholders of HVII. See “